Piperazine

Piperazine

SCHEMBL6559517

C1CNCCN1.O=S(=O)(Cl)c1ccc(C=Cc2ccc(S(=O)(=O)Cl)cc2)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 1/20 0.37
HTR2A P28223 3/20 0.37
KCNH2 Q12809 2/20 0.37
MAOB P27338 1/20 0.36
HTR2C P28335 2/20 0.34
HTR2B P41595 2/20 0.34
PTGS2 P35354 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557373 0.87 TDP1 (0.52) ALDH1A1HSD17B10TDP1MAPTHTR2A
SCHEMBL6557376 0.87 TDP1 (0.52) ALDH1A1HSD17B10TDP1MAPTHTR2A
SCHEMBL28814169 0.75 ALDH1A1 (0.44) ALDH1A1HSD17B10TDP1HTR2AKCNH2
SCHEMBL1373939 0.74 HCAR2 (0.57) ALDH1A1HSD17B10TDP1MAPTMAOB
SCHEMBL1375276 0.74 HCAR2 (0.57) ALDH1A1HSD17B10TDP1MAPTMAOB
SCHEMBL7224762 0.73 MAOB (0.44) ALDH1A1HSD17B10TDP1MAOBKDM4E
SCHEMBL14533597 0.73 ALDH1A1 (0.50) ALDH1A1HSD17B10TDP1MAPTKDM4E
SCHEMBL651902 0.72 ALDH1A1 (0.71) ALDH1A1HSD17B10TDP1LMNA
SCHEMBL351760 0.72 ALDH1A1 (0.50) ALDH1A1HSD17B10TDP1PTGS2KDM4E
SCHEMBL6559059 0.71 ALDH1A1 (0.33) ALDH1A1HSD17B10TDP1HTR2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0916394-B1 Method of manufacturing modified particles and manufacturing device therefor SHARP KK (JP) 2004-03-10 EP disclosed
US-6194487-B1 EXPOSURE OF PARTICLES TO SUPERSATURATED VAPOR OF MONOMERS, CONDENSATION AND POLYMERIZATION ON THE SURFACE SHARP KABUSHIKI KAISHA (JP) 2001-02-27 US disclosed
EP-0916394-A2 Method of manufacturing modified particles and manufacturing device therefor Sharp Kabushiki Kaisha (JP) 1999-05-19 EP disclosed